Adaptive Biotechnologies Corporation DSO Ratio 2011-2026 | ADPT

Annual DSO Ratio Adaptive Biotechnologies Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
60.7	81.3	83.6	56.6	32.5	42.2	54.4	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
83.6	32.5	58.7

Quarterly DSO Ratio Adaptive Biotechnologies Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
43.3	68.1	74.2	-	75.1	82	87.2	-	75.5	58.3	86.1	-	25.3	23.5	47.2	-	36.2	40.2	35.4	-	34.9	43.7	49.6	-	44.4	52.2	63	-	25.5	19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
87.2	19	51.7

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Altimmune ALT	7.85 K	$ 3.47	3.74 %	$ 306 M	USA
Amgen AMGN	81.2	-	-	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	70.9	-	-	$ 915 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Heron Therapeutics HRTX	198	-	-	$ 130 M	USA
Ascendis Pharma A/S ASND	132	$ 218.0	-1.75 %	$ 5 B	Danmark
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Incyte Corporation INCY	66.6	$ 90.75	-0.03 %	$ 17.7 B	USA
Inovio Pharmaceuticals INO	1.91 K	$ 1.57	-0.63 %	$ 34.8 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
KalVista Pharmaceuticals KALV	475	$ 16.73	-1.59 %	$ 831 M	Britain
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Denali Therapeutics DNLI	1.89	$ 21.04	4.31 %	$ 3.46 B	USA
Kamada Ltd. KMDA	103	$ 8.27	0.24 %	$ 260 M	Israel
Karyopharm Therapeutics KPTI	72.5	$ 6.93	-9.17 %	$ 845 K	USA
Keros Therapeutics KROS	4.72	$ 11.17	1.92 %	$ 416 M	USA
Arbutus Biopharma Corporation ABUS	31.5	$ 4.3	1.37 %	$ 714 M	Canada